Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Plasma Transfusion From Exercise-trained Donors in Patients With Early Alzheimer's Disease: The ExPlas Study

NCT05068830 is registered in ClinicalTrials.gov with Norwegian University of Science and Technology as lead sponsor.

NCT NCT05068830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05068830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Plasma Transfusion From Exercise-trained Donors in Patients With Early Alzheimer's Disease: The ExPlas Study
Lead sponsor
Norwegian University of Science and Technology
Phase
Phase 2
Overall status
Active, not recruiting
Start date
September 17, 2021
Completion date
March 1, 2031
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease